Caution should be made against the overprescription of lorazepam, as it can cause physical and/or psychological dependence especially in CHS patients who are vulnerable to substance abuse. Ironically, one of the potential complications of long-term cannabis use is a condition called cannabis hyperemesis syndrome (CHS). Serotonin antagonism in the gastrointestinal tract from medications such as ondansetron, dolasetron, and granisetron likewise have varying levels of efficacy. Opioids, while often prescribed for the patient’s debilitating abdominal pain, are not appropriate for CHS, as they may, in fact, worsen nausea and vomiting. Cannabinoid hyperemesis syndrome (CHS) is a very unpleasant — and potentially dangerous — complication of long-term marijuana use. Because of this possible complication, it’s important to use caution with marijuana and other cannabis products.
It’s important to be honest about your marijuana use if you have symptoms of cannabinoid hyperemesis syndrome CHS. Without knowing this background, providers often misdiagnose CHS as other conditions, like cyclic vomiting syndrome (CVS). One study found that 32.9% of self-reported frequent marijuana users who came to an emergency department for care met the criteria for CHS.
Additional pharmacological research is needed regarding the pro-emetic effects of additional cannabinoids and their metabolites. Another proposed explanation is that in susceptible individuals the pro-emetic effect of cannabis on the gut (e.g. delayed gastric emptying) overrides its anti-emetic CNS properties 62. This hypothesis is supported by the demonstration of delayed gastric emptying on gastric emptying scintigraphy in some cases 6,55,62. Further research is required to investigate the gastrointestinal physiology in these patients during both the acute attacks of hyperemesis and between episodes. There exists no epidemiological data regarding the incidence and prevalence of CHS among chronic marijuana users. The syndrome is likely underreported given its recent recognition 74,75.
As more states make recreational use of cannabis legal, it is thought that this problem will become more common. After stopping cannabis use, symptoms typically start to disappear within one to two days though individual results can vary. However, symptoms almost always return if you resume using marijuana. Since its symptoms are easily confused with other conditions, it can take about one to two years before people who seek medical help with CHS get an accurate diagnosis. Cannabinoid hyperemesis syndrome (CHS) is a rare problem that causes constant vomiting. The pain is usually around the belly button and can get better with hot shower/baths.
Cannabis legalization and acceptance have brought us to a brave new world, in the sense of how William Shakespeare first coined the phrase—a world of naive innocence, rather than a hoped-for utopia. The only way to prevent CHS is to avoid using any form of marijuana. It’s still possible to develop CHS if you use cannabis for many years without having any problems. THC and other chemicals in cannabis also bind to molecules in your digestive tract.
Anandamide and 2-AG are released locally on demand by neurons, are present in small quantities, and undergo rapid inactivation 8. Endocannabinoids are thought to act as either neuromodulators or neurotransmitters https://ecosoberhouse.com/article/abuse-in-older-adults-a-growing-threat/ 11. Anandamide and 2-AG possess similar biochemical structures, but each has a distinct pathway for biosynthesis and degradation.
Diagnosis begins with a thorough physical examination and history for all patients presenting with nausea, vomiting, and abdominal pain. This will help to rule out life-threatening causes or diagnoses that confer significant potential morbidity to the patient or to establish the presumptive diagnosis of CHS. History taking should include an inquiry about the patient’s past and present medical illness, medication use, illicit drug use, and therapeutic or recreational use of cannabis. Denial of cannabis use by the patient is typically the biggest stumbling block for clinicians in making a proper diagnosis of CHS.
CHS is a newly identified condition, so doctors currently know little about it. No clinical guidelines exist, so they must rely on published case reports to treat people with CHS. However, doctors exercise caution when prescribing lorazepam because it is a controlled substance with the potential for abuse and addiction. The use of lorazepam for CHS is also off-label, so a person’s doctor would need to make them aware of this fact.
As people with CHS often only consult their doctors during the hyperemesis stage, there is a lack of knowledge regarding the treatment of people during the prodromal stage. Clinical guidelines for the diagnosis of CHS do not currently exist. Some researchers have published their findings from their personal experience with the condition in clinical journals. In CHS, receptors that bind to the different components of marijuana can become altered. Some receptors may become more active, while others can shut down. On the basis that only a small number of regular and long term users of marijuana develop CHS, some researchers suggest that genetics might play a role.
While marijuana seems to bring on nausea in the stomach, in the brain it usually has opposite effect. When cannabinoids bind with brain receptors, they tend to prevent nausea and vomiting. Experts think that when you first smoke weed, your brain signals are more important, but after repeated use of the drug, the brain receptors may no longer respond to marijuana in the same way, causing more nausea and vomiting. When you use marijuana for many years, it can start to slowly change how the receptors in your body respond to the cannabinoid chemicals. For example, the drug affects the receptors in the esophageal sphincter, the tight band of muscle that opens and closes to let food go from your throat to your stomach.